| Negativity towards negative results: a discussion of the disconnect between scientific worth and scientific culture N Matosin, E Frank, M Engel, JS Lum, KA Newell Disease models & mechanisms 7 (2), 171-173, 2014 | 175 | 2014 |
| Understanding the molecular mechanisms underpinning gene by environment interactions in psychiatric disorders: the FKBP5 model N Matosin, T Halldorsdottir, EB Binder Biological psychiatry 83 (10), 821-830, 2018 | 93 | 2018 |
| Metabotropic glutamate receptor 5 in the pathology and treatment of schizophrenia N Matosin, KA Newell Neuroscience & Biobehavioral Reviews 37 (3), 256-268, 2013 | 75 | 2013 |
| Metabotropic glutamate receptor mGluR2/3 and mGluR5 binding in the anterior cingulate cortex in psychotic and nonpsychotic depression, bipolar disorder and schizophrenia … N Matosin, F Fernandez-Enright, E Frank, C Deng, J Wong, XF Huang, ... Journal of psychiatry & neuroscience: JPN 39 (6), 407, 2014 | 48 | 2014 |
| Molecular evidence of synaptic pathology in the CA1 region in schizophrenia N Matosin, F Fernandez-Enright, JS Lum, M Engel, JL Andrews, ... npj Schizophrenia 2 (1), 1-8, 2016 | 37 | 2016 |
| Homer1/mGluR5 activity moderates vulnerability to chronic social stress KV Wagner, J Hartmann, C Labermaier, AS Häusl, G Zhao, D Harbich, ... Neuropsychopharmacology 40 (5), 1222-1233, 2015 | 35 | 2015 |
| Metabotropic glutamate receptor 5 binding and protein expression in schizophrenia and following antipsychotic drug treatment N Matosin, E Frank, C Deng, XF Huang, KA Newell Schizophrenia research 146 (1-3), 170-176, 2013 | 34 | 2013 |
| Preclinical and clinical evidence of DNA methylation changes in response to trauma and chronic stress N Matosin, C Cruceanu, EB Binder Chronic Stress 1, 2470547017710764, 2017 | 30 | 2017 |
| Shifting towards a model of mGluR5 dysregulation in schizophrenia: consequences for future schizophrenia treatment N Matosin, F Fernandez-Enright, JS Lum, KA Newell Neuropharmacology 115, 73-91, 2017 | 25 | 2017 |
| Rethinking metabotropic glutamate receptor 5 pathological findings in psychiatric disorders: implications for the future of novel therapeutics KA Newell, N Matosin BMC psychiatry 14 (1), 1-6, 2014 | 25 | 2014 |
| Alterations of mGluR5 and its endogenous regulators Norbin, Tamalin and Preso1 in schizophrenia: towards a model of mGluR5 dysregulation N Matosin, F Fernandez-Enright, SJ Fung, JS Lum, M Engel, JL Andrews, ... Acta neuropathologica 130 (1), 119-129, 2015 | 24 | 2015 |
| Metabotropic glutamate receptor 5, and its trafficking molecules Norbin and Tamalin, are increased in the CA1 hippocampal region of subjects with schizophrenia N Matosin, F Fernandez-Enright, JS Lum, JL Andrews, M Engel, ... Schizophrenia research 166 (1-3), 212-218, 2015 | 18 | 2015 |
| Neurodevelopmental expression profile of dimeric and monomeric group 1 mGluRs: relevance to schizophrenia pathogenesis and treatment JS Lum, F Fernandez, N Matosin, JL Andrews, XF Huang, L Ooi, ... Scientific reports 6 (1), 1-10, 2016 | 16 | 2016 |
| Interactions of early-life stress with the genome and epigenome: from prenatal stress to psychiatric disorders C Cruceanu, N Matosin, EB Binder Current Opinion in Behavioral Sciences 14, 167-171, 2017 | 14 | 2017 |
| Alterations of ubiquitin related proteins in the pathology and development of schizophrenia: Evidence from human and animal studies JL Andrews, FJ Goodfellow, N Matosin, MK Snelling, KA Newell, ... Journal of psychiatric research 90, 31-39, 2017 | 13 | 2017 |
| Effects of common GRM5 genetic variants on cognition, hippocampal volume and mGluR5 protein levels in schizophrenia N Matosin, KA Newell, Y Quidé, JL Andrews, N Teroganova, MJ Green, ... Brain imaging and behavior 12 (2), 509-517, 2018 | 9 | 2018 |
| Alterations of p75 neurotrophin receptor and Myelin transcription factor 1 in the hippocampus of perinatal phencyclidine treated rats JL Andrews, KA Newell, N Matosin, XF Huang, F Fernandez-Enright Progress in Neuro-Psychopharmacology and Biological Psychiatry 63, 91-97, 2015 | 6 | 2015 |
| Possibility of a sex-specific role for a genetic variant in FRMPD4 in schizophrenia, but not cognitive function N Matosin, MJ Green, JL Andrews, KA Newell, F Fernandez-Enright Neuroreport 27 (1), 33-38, 2016 | 5 | 2016 |
| NMDA receptor antagonism by phencyclidine reduces NWASP and WAVE1 protein expression and reduces levels of myelination markers in the prefrontal cortex of rats JL Andrews, KA Newell, N Matosin, XF Huang, F Fernandez-Enright | 5 | 2015 |
| Metabotropic glutamate receptor in the pathophysiology and treatment of schizophrenia and major depression KA Newell, N Matosin, JS Lum | 4 | 2014 |
Elisabeth BinderVerified email at psych.mpg.de
